Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
COMBINATION OF DASATINIB AND ADAGRASIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
No-Receipt date
2025-01261 - 10/04/2025
No-Filing date
20250400758 - 10/04/2025
No-Granting date
3118003 - 29/04/2025
No-EPO application date
19858883.2 - 09/09/2019
No-EPO granting date
3849534 - 05/03/2025
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
4/2025 - 14/05/2025
Expiration date
10/09/2039
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201862729169 P10/09/2018/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/5025
A61K 31/506
A61K 31/517
A61K 31/519
A61K 31/5377
A61K 31/541
A61K 31/553
A61K 45/06
A61K 9/00
A61P 35/00
A61P 35/02
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1734849
MIRATI THERAPEUTICS, INC.
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NEW JERSEY 08543
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
4552272
ENGSTROM, LARS, DANIEL
4552273
ARANDA, RUTH, WEI
4552274
OLSON, PETER
4552275
CHRISTENSEN, JAMES, GAIL
Representatives
Code
Firstname
Surname
Address
Town
Zip
3713
ALKISTIS-EIRINI
MALAMI
VISSARIONOS 3
ATHINA (ATTIKIS)
10672
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
9219
ALKISTIS-EIRINI
MALAMI
VISSARIONOS 3
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Title Instruments
Payments history
6 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).